Compare EXAS & IFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXAS | IFF |
|---|---|---|
| Founded | 1995 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3B | 19.6B |
| IPO Year | N/A | N/A |
| Metric | EXAS | IFF |
|---|---|---|
| Price | $101.91 | $68.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 15 |
| Target Price | $77.94 | ★ $85.15 |
| AVG Volume (30 Days) | ★ 4.9M | 2.3M |
| Earning Date | 02-18-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 2.36% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,082,033,000.00 | ★ $11,072,000,000.00 |
| Revenue This Year | $19.40 | N/A |
| Revenue Next Year | $13.51 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.47 | N/A |
| 52 Week Low | $38.81 | $59.14 |
| 52 Week High | $102.66 | $88.09 |
| Indicator | EXAS | IFF |
|---|---|---|
| Relative Strength Index (RSI) | 85.29 | 60.20 |
| Support Level | $101.45 | $66.15 |
| Resistance Level | $102.00 | $67.05 |
| Average True Range (ATR) | 0.39 | 1.24 |
| MACD | -1.26 | 0.25 |
| Stochastic Oscillator | 88.69 | 95.39 |
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients.